This company has been marked as potentially delisted and may not be actively trading. Allena Pharmaceuticals (ALNA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ALNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Allena Pharmaceuticals Inc ALNAQ Stock QuoteNovember 4, 2023 | morningstar.comMAllena Pharmaceuticals Inc (ALNAQ)August 28, 2023 | investing.comSan Francisco Pharmaceuticals NewsMay 6, 2023 | bizjournals.comALNA.OSeptember 29, 2022 | reuters.comFirm Retention Summary: Allena Pharmaceuticals Inc.September 6, 2022 | wsj.comAllena Pharmaceuticals Shares Fall After Filing For BankruptcySeptember 6, 2022 | finance.yahoo.comAllena Pharmaceuticals (Nasdaq:ALNA) HeadlineTrading was temporarily halted for "ALNA" at 05:09 PM with a stated reason of "News pending."...September 2, 2022 | marketbeat.comAllena Pharma Needs To Raise Capital To Continue As A Going ConcernAugust 11, 2022 | finance.yahoo.comAllena Pharmaceuticals Warns of Imminent Funding Need >ALNAAugust 11, 2022 | marketwatch.comAllena Pharmaceuticals (Nasdaq:ALNA) HeadlineTrading was temporarily halted for "ALNA" at 07:08 AM with a stated reason of "News pending."...August 11, 2022 | marketbeat.comAllena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney DiseaseJuly 19, 2022 | finance.yahoo.comAllena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock SplitJuly 12, 2022 | finance.yahoo.comAllena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock SplitJuly 12, 2022 | finance.yahoo.comAllena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock SplitJuly 5, 2022 | apnews.comAAllena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock SplitJuly 5, 2022 | finance.yahoo.comWhy Shares Of Allena Pharmaceuticals Are Skyrocketing TodayJuly 1, 2022 | uk.investing.comALNA Stock Alert: What to Know as Allena Pharmaceuticals Soars 200%June 29, 2022 | investorplace.comShort Volatility Alert: Allena PharmaceuticalsMay 16, 2022 | msn.comALNA Stock Alert: 5 Things to Know as Little-Known Allena Pharmaceuticals Soars 100%May 12, 2022 | investorplace.comNano cap stock Allena surges on heavy volumeMay 12, 2022 | seekingalpha.comAllena Pharmaceuticals $2.8M direct offeringMay 4, 2022 | seekingalpha.comAllena Pharmaceuticals Announces $2.8 Million Registered Direct OfferingMay 4, 2022 | finance.yahoo.comAllena Pharmaceuticals (NASDAQ:ALNA) Rating Increased to Hold at Zacks Investment ResearchMarch 23, 2022 | marketbeat.comAllena downgraded to Neutral at B. Riley citing the end to lead clinical programMarch 22, 2022 | seekingalpha.comWhy Are Allena Pharma Shares Plunging TodayMarch 21, 2022 | finance.yahoo.comAllena extends losses on plans to end trial for lead asset and financial concernsMarch 21, 2022 | seekingalpha.comAllena Pharmaceuticals (Nasdaq:ALNA) HeadlineTrading was temporarily halted for "ALNA" at 04:03 PM with a stated reason of "News pending."...March 18, 2022 | marketbeat.comAllena Pharmaceuticals, Inc. (ALNA)March 1, 2022 | finance.yahoo.comAllena Pharmaceuticals, Inc.(ALNA)January 29, 2022 | fool.comAllena Pharmaceuticals (NASDAQ:ALNA) Lowered to "Hold" at Zacks Investment ResearchJanuary 14, 2022 | marketbeat.comWedbush Weighs in on Allena Pharmaceuticals, Inc.'s FY2021 Earnings (NASDAQ:ALNA)January 7, 2022 | marketbeat.comThinking about buying stock in Allena Pharmaceuticals, Carnival Corp, Oragenics, NLS Pharmaceutics, or BP?January 4, 2022 | morningstar.comMAllena Stock Is Surging In Premarket Today As It Explores Strategic, Financing AlternativesJanuary 4, 2022 | finance.yahoo.comAllena Pharmaceuticals Provides Clinical and Corporate UpdateJanuary 4, 2022 | finance.yahoo.comAllena Pharmaceuticals (NASDAQ:ALNA) Stock Rating Upgraded by Zacks Investment ResearchDecember 27, 2021 | marketbeat.comAllena Pharmaceuticals (ALNA) Sees Hammer Chart Pattern: Time to Buy?November 22, 2021 | finance.yahoo.comAfter Plunging 19.7% in 4 Weeks, Here's Why the Trend Might Reverse for Allena Pharmaceuticals, Inc. (ALNA)November 22, 2021 | finance.yahoo.comAllena Pharmaceuticals, Inc. (ALNA) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowNovember 22, 2021 | finance.yahoo.comAllena Pharmaceuticals to Participate in the Stifel 2021 Virtual Healthcare ConferenceNovember 15, 2021 | finance.yahoo.comAllena Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Corporate ProgressNovember 10, 2021 | finance.yahoo.comAllena Pharmaceuticals Gets Fast Track Designation for Kidney Disease TreatmentNovember 3, 2021 | marketwatch.comAllena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney DiseaseNovember 3, 2021 | finance.yahoo.comAllena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346September 29, 2021 | finance.yahoo.comAllena Pharmaceuticals to Participate in H.C. Wainwright’s 23rd Annual Global Investment ConferenceSeptember 9, 2021 | finance.yahoo.comAllena Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Corporate ProgressAugust 10, 2021 | finance.yahoo.com Get Allena Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter. Email Address ALNA Media Mentions By Week ALNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNA News Sentiment▼0.000.99▲Average Medical News Sentiment ALNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNA Articles This Week▼00▲ALNA Articles Average Week Get Allena Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Prime Medicine News Today Inhibikase Therapeutics News Today Protalix BioTherapeutics News Today Invizyne Technologies News Today Achilles Therapeutics News Today ZIVO Bioscience News Today bluebird bio News Today Cyclo Therapeutics News Today NKGen Biotech News Today AlloVir News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allena Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allena Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
